TABLE 2

Estimated Survival and Time to Progression After Radical Surgery

Factor	Group (no.)	% surviving at 3 y^*	P value	% progression free at 3 y^*	P value
All patients	30	83 (65–93)		73 (51–87)
PET response
CMR	17	100		100
PMR	10	79 (44–95)		47 (14–83)
SMD/PMD	3	0	<0.0001^†	0	<0.0001^†
CT/MRI response
CR	5	100		100
No CR	19	78 (54–92)	0.35	66 (41–84)	0.22
Tumor at surgery
No tumor	6	100		100
Primary site only	15	86 (57–96)		60 (24–88)
Primary and nodes	9	67 (33–89)	0.027^†	67 (33–89)	0.021^†
Primary site
No	6	100		100
Yes	24	78 (57–91)	0.28	63 (35–84)	0.12
Lymph nodes
No	21	90 (67–98)		76 (49–92)
Yes	9	67 (33–89)	0.11	67 (33–89)	0.23
T stage on structural imaging
T3	26	89 (70–96)		76 (51–91)
T4	4	50 (12–88)	0.15	50 (12–88)	0.19

↵* Estimated percent values expressed with 95% confidence limits (in parentheses).
↵† Test for trend.
Group = number of patients.